Search results for: 'update linux grid 20 ubuntu'

This research service aims to provide an update on the epidemiology of rheumatoid arthritis, current diagnostic and treatment practices, as well as market landscape in terms of major participants and future trends. It covers the rheumatoid arthritis therapeutics market in Thailand.

This research service aims to provide an update on the epidemiology of rheumatoid arthritis, current diagnostic and treatment practices, as well as market landscape in terms of major participants and future trends. It covers the rheumatoid arthritis therapeutics market in India.

This research service aims to provide an update on the epidemiology of rheumatoid arthritis, current diagnostic and treatment practices, as well as market landscape in terms of major participants and future trends. It covers the rheumatoid arthritis therapeutics market in the Philippines.

The 20th annual World Diabetes Congress of the International Diabetic Federation mentions that India leads the world in the looming epidemic of diabetes. The concept of Self-Monitoring of Blood Glucose (SMBG) was introduced in India only a few years back, and the industry has already grown to about $49.7 million with a growth rate of over 20 per...

The In-vitro Diagnostics (IVD) market in China shows strong growth potential in several segments. Market growth is set to be driven by the growing volume of tests, rather than the higher price of testing solutions in traditional segments and the popularization of advanced testing technology in emerging segments. In the context of the reform in publ...

This market insight aims to profile select medical device companies in Asia-Pacific for 2016. Research Scope: • The aim of this insight is to analyze and profile APAC medical device manufacturers, based on certain parameters. • It covers wound management, cardiovascular, orthopedic implants, infection control, and infusion the...

10 Jan 2018  |  Asia Pacific  |  Market Research

APAC Biosimilar Market, Forecast 2025

Patent Expiries, Defined Regulatory Pathways, and Escalating Healthcare Costs to Boost Growth

Infographics

×

Key Issues Addressed Key Benefits

Biosimilars is a massive opportunity; regardless of a slow start, the market will eventually be a huge business. As per Frost & Sullivan’s estimate, biologic drugs worth $70–$80 billion will lose exclusivity in the next 5 years globally and APAC’s contribution would be more than 20%. Countries in the region, such as India, China, and South Korea, o...